Stocks in Focus on May 8: RBL Bank, NBFC, PSBs to HUL; here are expected Newsmakers of the Day
Stocks in Focus on May 8: RBL Bank, ICICI Securities, Cyient, Cadila healthcare, etc. ae expected newsmakers throughout the intraday tade session.
The domestic share markets closed with modest losses on Thursday, 7 May 2020. The barometer S&P BSE Sensex lost 242.37 points or 0.76% at 31,443.38. The Nifty 50 index fell 71.85 points or 0.78% at 9,199.05. But certain stocks came in news after the market was closed. These stocks can impact the indices when it reopens on Friday, May 8, 2020. List of such five stocks:
RBL Bank/ ICICI Securities/ Cyient/ Gillette/ SKF India: These companies have declared their March quarter results on Thursday after the market hours.
See Zee Business Live TV streaming below:
RBL Bank: The private lender announced its financial results for the quarter and year ended March 31, 2020, on Thursday and reported a 53.7% year-on-year (YoY) fall in net profit to Rs 114 crore from Rs 247 crore posted in the corresponding period last year. The net interest income (NII) of the bank rose 38% to Rs 1,021 crore in Q4FY2 from Rs 739 crore in Q4FY19. The net interest margin (NIM) rose by 70 basis points to 4.93 % compared to 4.23% in the same period a year ago. NIM is at a new all-time high of 4.93% in Q4 FY20. The bank’s gross non-performing assets (NPA) also shot up to 3.62% compared to 3.3% reported in the December quarter of FY20. The net NPAs ratio also moved up to 2.05% quarter-on-quarter (QoQ) against 2.07% posted on Q3Fy20. The slippage ratio fell to 1.19 per cent in the period under review as opposed to 1.79 per cent in Q3FY19. Provisions and contingencies of the bank rose 207% to Rs 614 crore against Rs 200 crore reported in the Q4FY19. The management said, nearly one-third of the bank’s borrowers opted for a moratorium. Nearly 13 per cent of the bank's credit card customers also opted for a moratorium.
ICICI Securities (I-Sec): I-Sec, a part of the ICICI Group on Thursday announced the financial results for the quarter (Q4FY20) and reported 28.3% year-on-year rise in consolidated profit at Rs 155.9 crore against Rs 121.5 crore posted in the same quarter of last fiscal, FY19. Revenue grew 17.7% to Rs 480.4 crore against Rs 408.1 crore reported last year. EBITDA stood at Rs 251.3 crore, up 37.6%, from Rs 182.6 crore of Q4FY19. Besides, the company’s board has recommended a final dividend of Rs. 6.75 per equity share.
Cyient: Cyient Limited has reported financial results for the period ended March 31, 2020, and posted 58.3% quarter-on-quarter (QoQ) fall in consolidated profit to Rs 45.2 crore from Rs 108.3 crore posted in December quarter. Its revenue declined by 2.9% to Rs 1,073.6 crore compared to Rs 1,105.9 crore posted in the previous quarter. EBIT fell 55.6% to Rs 45.4 crore from Rs 105.3 crore, while the margin of March quarter stood at 4.2% against 9.5% reported in Q3FY20.
Gillette India: GIL on Thursday announced its financial results for the quarter ended March 31, 2020, and reported 40.3% year-on-year fall in consolidated profit at Rs 52.4 crore from Rs 87.8 crore posted in the corresponding period last year. Its revenue declined 12.7% to Rs 406.6 crore from Rs 465.5 crore posted in Q4FY19. EBITDA was Rs 80.5 crore 44.9% down from Rs 146.1 crore posted last year.
SKF India: SKF India Ltd has reported financial results for the period ended March 31, 2020, and reported 8.3% year-on-year fall in consolidated profit at Rs 75.34 crore from Rs 82.2 crore posted in the corresponding quarter of FY19. Its revenue stood at Rs 610.2 crore, down 18.5%, from Rs 748.4 crore posted last year. Its EBITDA fell 44.2% to Rs 61.9 crore against Rs 111 crore of Q4FY19. Besides, the company’s board has recommended a special dividend as a final dividend of Rs. 130 per equity share for the financial year ended March 31, 2020.
Cadila healthcare/ Neuland Labs: Cadila Healthcare has received final approval from USFDA to market Deferasirox tablets for oral suspension in the strengths of 125 mg, 250 mg and 500 mg. Deferasirox binds to iron and removes it from the bloodstream. It is used to treat iron overload caused by blood transfusions in adults and children who are at least 2 years old. It is also used to treat chronic iron overload syndrome caused by a genetic blood disorder (non-transfusion dependent thalassemia) in adults and children who are at least 10 years old. Besides, Neuland Lab has received an Establishment Inspection Report (EIR) from the USFDA for its manufacturing facility located at Pashamylaram, Hyderabad. The facility was inspected from February 3-7, 2020. The inspection has now been closed by the USFDA.
NBFC/PSBs in Focus: NBFC and PSBs will be in focus today as Finance Minister Nirmala Sitharaman tweet said, “During March-April 2020, PSBs sanctioned loans worth Rs 5.66 lakh cr for more than 41.81 lakh accounts. These borrowers are from MSME, retail, agriculture and corporate sectors, waiting for disbursal soon after #lockdown lifts. Economy poised to recover!” She also said that NBFCs and Housing Finance Companies, PSBs sanctioned Rs 77,383 crore between March 1 and May 4. Inclusive of targeted long term repo operations funds, there has been extended total financing of Rs 1.08 lakh crore which has ensured business stability and continuity.
Power Companies in Focus: Government is likely to issue an advisory to central public sector enterprises (CPSEs) to halve the fixed charges they collect from state power distribution companies (DISCOMS).
Hindustan Unilever (HUL): Foreign portfolio investor (FPI) Societe Generale picked up 1.29 crore shares in Hindustan Unilever (HUL) on Thursday. The purchase was made via bulk deals from British drugmaker GlaxoSmithKline Pte.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.